Related references
Note: Only part of the references are listed.Immunohistochemical expression of HER2 in breast cancer: socioeconomic impact of inaccurate tests
Mogens Vyberg et al.
BMC HEALTH SERVICES RESEARCH (2015)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
HER2 Gene Amplification in Breast Cancer A Rogues' Gallery of Challenging Diagnostic Cases: UKNEQAS Interpretation Guidelines and Research Recommendations
Jane Starczynski et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Image Analysis of HER2 Immunohistochemical Staining Reproducibility and Concordance With Fluorescence In Situ Hybridization of a Laboratory-Validated Scoring Technique
Douglas M. Minot et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Quantitative Assessment and Classification of Tissue-Based Biomarker Expression With Color Content Analysis
Brad Keller et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Digital image analysis of membrane connectivity is a robust measure of HER2 immunostains
Anja Brugmann et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
ImmunoMembrane: a publicly available web application for digital image analysis of HER2 immunohistochemistry
Vilppu J. Tuominen et al.
HISTOPATHOLOGY (2012)
HER2 testing in gastric cancer: a practical approach
Josef Rueschoff et al.
MODERN PATHOLOGY (2012)
Evaluating tumor heterogeneity in immunohistochemistry-stained breast cancer tissue
Steven J. Potts et al.
LABORATORY INVESTIGATION (2012)
The case for open computer programs
Darrel C. Ince et al.
NATURE (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Effects of the Change in Cutoff Values for Human Epidermal Growth Factor Receptor 2 Status by Immunohistochemistry and Fluorescence In Situ Hybridization A Study Comparing Conventional Brightfield Microscopy, Image Analysis-Assisted Microscopy, and Interobserver Variation
Roscoe Atkinson et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2011)
Beyond trastuzumab: New treatment options for HER2-positive breast cancer
Kamal S. Saini et al.
BREAST (2011)
Current technologies for HER2 testing in breast cancer
C. B. Moelans et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2011)
Membrane connectivity estimated by digital image analysis of HER2 immunohistochemistry is concordant with visual scoring and fluorescence in situ hybridization results: algorithm evaluation on breast cancer tissue microarrays
Aida Laurinaviciene et al.
DIAGNOSTIC PATHOLOGY (2011)
Quality assessment of HER2 testing by monitoring of positivity rates
Harald Choritz et al.
VIRCHOWS ARCHIV (2011)
Diagnostic Value of Automated Her2 Evaluation in Breast Cancer A Study on 272 Equivocal (score 2+) Her2 Immunoreactive Cases Using an FDA Approved System
Chiara Cantaloni et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2011)
An invitation to reproducible computational research
David L. Donoho
BIOSTATISTICS (2010)
Image analysis as an adjunct to manual HER-2 immunohistochemical review: a diagnostic tool to standardize interpretation
Lynne Dobson et al.
HISTOPATHOLOGY (2010)
Human Epidermal Growth Factor Receptor 2 Testing: Where Are We?
Pradip De et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Digital pathology: exploring its applications in diagnostic surgical pathology practice
Ana Richelia Jara-Lazaro et al.
PATHOLOGY (2010)
Automated Cellular Imaging System III for Assessing HER2 Status in Breast Cancer Specimens Development of a Standardized Scoring Method That Correlates With FISH
Douglas M. Minot et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Inter-observer reproducibility of HER2 immunohistochemical assessment and concordance with fluorescent in situ hybridization (FISH): pathologist assessment compared to quantitative image analysis
Gulisa Turashvili et al.
BMC CANCER (2009)
Automated Quantitative Assessment of HER-2/neu Immunohistochemical Expression in Breast Cancer
Hela Masmoudi et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2009)
Guidelines for Human Epidermal Growth Factor Receptor 2 Testing: Biologic and Methodologic Considerations
Guido Sauter et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Systematic Review of HER2 Breast Cancer Testing
Marta Cuadros et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2009)
Current issues in ER and HER2 testing by IHC in breast cancer
Allen M. Gown
MODERN PATHOLOGY (2008)
Computer-assisted assessment of the Human Epidermal Growth Factor Receptor 2 immunohistochemical assay in imaged histologic sections using a membrane isolation algorithm and quantitative analysis of positive controls
Bonnie H Hall et al.
BMC MEDICAL IMAGING (2008)
Multiple immunoenzyme staining: Methods and visualizations for the observation with spectral imaging
Chris M. van der Loos
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2008)
Frequency and reliability of oestrogen receptor, progesterone receptor and HER2 in breast carcinoma determined by immunohistochemistry in Australasia: results of the RCPA Quality Assurance Program
Glenn D. Francis et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Testing for HER2-positive breast cancer: a systematic review and cost-effectiveness analysis
Nandini Dendukuri et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2007)
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Refinement of immunohistologic parameters for Her2/neu scoring validation by FISH and CISH
Anthony S-Y Leong et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2006)
Quantification of immunohistochemistry - issues concerning methods, utility and semiquantitative assessment I
R. A. Walker
HISTOPATHOLOGY (2006)
Critical comparison of 31 commercially available digital slide systems in pathology
Marcial Garcia Rojo et al.
INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY (2006)
Concordance between central and local laboratory HER2 testing from a community-based clinical study
Josina C. Reddy et al.
CLINICAL BREAST CANCER (2006)
Share Paper
